These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1329443

  • 1. Stimulation of host-defense mechanism with synthetic adjuvants and recombinant cytokines against viral infection in mice.
    Azuma I, Ishihara C, Iida J, Yoo YC, Yoshimatsu K, Arikawa J.
    Adv Exp Med Biol; 1992; 319():253-63. PubMed ID: 1329443
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
    Ishihara C, Hamada N, Yamamoto K, Iida J, Azuma I, Yamamura Y.
    Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
    [Abstract] [Full Text] [Related]

  • 5. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
    Saiki I, Saito S, Fujita C, Ishida H, Iida J, Murata J, Hasegawa A, Azuma I.
    Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
    [Abstract] [Full Text] [Related]

  • 6. Protective activity of recombinant cytokines against Sendai virus and herpes simplex virus (HSV) infections in mice.
    Iida J, Saiki I, Ishihara C, Azuma I.
    Vaccine; 1989 Jun; 7(3):229-33. PubMed ID: 2476892
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experimental and clinical studies on the effects of synthetic muramyldipeptide derivatives on viral and opportunistic infections.
    Yamamura Y, Ishihara C, Hamada N, Yamamoto K, Azuma I.
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):11-4. PubMed ID: 3010013
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective effect of MDP-Lys(L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection.
    Eizuru Y, Nakagawa N, Hamasuna R, Minamishima Y.
    Nat Immun; 1992 Jan; 11(4):225-36. PubMed ID: 1384831
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L, Burke RL, Ott G, Van Nest G.
    J Immunol; 1988 Sep 01; 141(5):1720-7. PubMed ID: 2842401
    [Abstract] [Full Text] [Related]

  • 15. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.
    Yoo YC, Saiki I, Sato K, Azuma I.
    Vaccine; 1994 Feb 01; 12(2):175-60. PubMed ID: 8147100
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of non-specific resistance to infection by muroctasin.
    Otani T, Une T, Osada Y.
    Arzneimittelforschung; 1988 Jul 01; 38(7A):969-76. PubMed ID: 3056426
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
    Osada Y, Mitsuyama M, Matsumoto K, Une T, Otani T, Ogawa H, Nomoto K.
    Infect Immun; 1982 Sep 01; 37(3):1285-8. PubMed ID: 6752024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.